Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • emyoung90
    Junior Member
    • Apr 2017
    • 1

    #1

    Overcoming PCR Primer Bias with MiSeq?

    Hi, I am a grad student new to MiSeq and HTS in general. I'm trying to figure out which sequencing kit/method to use for my project, and I'm getting some mixed responses. I have spoken to 5-6 people on the matter (some of whom work at Illumina), and both TruSeq Custom Amplicon sequencing and Nextera XT have been suggested - I'm just trying to figure out the best way to go about this, since my budget is limited.

    Background: I am trying to detect co-infections of malaria strains in host DNA samples. There are 5 lineages/strains that I am looking for, all of which we have unique sequence fragments for from PCR/Sanger methods.

    Issue: The primers and PCR/Sanger sequencing protocol we have are great for amplifying and identifying the dominant lineage present, but the issue is that the primers are biased - they will amplify some lineages over others for various reasons. We want to study co-infections of multiple lineages in a single sample, but our PCR/Sanger methods cannot determine co-infection due to that bias.

    The sequences we have are all from the malaria cyt-b gene (mtDNA), fragments are about 500-550 bp long, and the sequences are fairly conserved between lineages - they average about 10 nucleotides different from each other. As such, I can't develop lineage-specific primers for PCR, as the sequences are too similar.

    Goal: To use a high-throughput technique to target that same region (so that we can use our lab database to identify the lineages). I had thought to use a
    generic malaria probe (one that will bind with any malaria present, but not with any host DNA), but I need to ensure somehow that the same primer bias described before won't negatively affect results. I would think that would be remedied by read depth, but I admit that I am new to HTS-related techniques so I'm not sure.

    I had been considering TruSeq Custom Amplicon sequencing, but because my target area is so short (~600 bp), that method would probably not be cost effective. Can anyone give any advice on this? Thanks.
  • thermophile
    Senior Member
    • Apr 2015
    • 243

    #2
    You could do direct amplicon sequencing, the way that most people are doing 16s for bacterial communities. (see Kozich 2013 or Caporasso 2012). Depending on how many samples you have, you may want to design your own primers or use a 2-step method (Lange 2014)

    I run a core facility that specialized in amplicon sequencing, you can check out my website for some documentation and visualizations. mars.uconn.edu
    Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

    Comment

    • fanli
      Senior Member
      • Jul 2014
      • 197

      #3
      I would tend to agree with @thermophile that custom primers would be the way to go here. If you are on a limited budget, Illumina kits tend to be quite expensive on a per-sample basis.

      If you are trying to detect co-infections, then yes, simply having tens or hundreds of thousands of reads per sample of any malarial DNA should in theory be sufficient. If you are trying to measure co-infections in a quantitative sense, then I would be more worried about primer bias. Then you could do something like a synthetic control of known lineage amounts, and see how reproducibly you can recover this ground truth using your assay.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      51 views
      0 reactions
      Last Post SEQadmin2  
      Working...